Jan 29, 2019

It’s no secret that a focus on patient experience leads to value and ROI. Technology investments require a strong ROI case in order to get funded, but as the industry shifts from systems of record (EHR) to systems of engagement, new dimensions of value arise that add up to 7- or 8-figure numbers for the bigger medical...

Jan 29, 2019

In 2018, the average cost of developing a new drug and bringing it to market topped $2.1 billion—up $362 million from 2017 according to a Deloitte survey. One of the challenges pharmaceutical companies face is attrition and non-adherence during patient trials. Traditional methods, focused on call centers, complex...